首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Development and Characterization of Bioadhesive Gel of Microencapsulated Metronidazole for Vaginal Use
【2h】

Development and Characterization of Bioadhesive Gel of Microencapsulated Metronidazole for Vaginal Use

机译:微囊甲硝唑阴道用生物胶的研制与表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The present study concerned with the development and characterization of metronidazole microcapsules prepared by thermal change method using different ratios (1:1, 1:2 and 1:4) of ethyl cellulose in order to select the best microcapsule formulation with a good encapsulation efficiency and drug release profile. The obtained microcapsules were discrete, spherical with free flowing properties and evaluated for particle size, shape, flow properties, wall thickness, drug encapsulation efficiency and in vitro release performance. The drug carrier interactions were investigated in solid state by FT-IR spectroscopy and scanning electron microscopy. The microcapsules with a narrow size range of 23-68 μm showed higher encapsulation efficiency. The selected microcapsule formulation, MC3 (Drug polymer ratio 1:4) was employed for gel formulation with a variety of carbopol polymers (carbopol-934, 940, 974 and 980) by mechanical stirring method in order to develop a sustained release microencapsulated metronidazole microcapsules-containing bioadhesive gel. The prepared bioadhesive gels were evaluated for pH, spreadability, extrudability, viscosity, vaginal irritation, in vitro drug release, bioadhesion, accelerated stability and in vitro drug release kinetic. In vitro experiments indicated a sustained release over 24 h and an acceptable bioadhesion quality for formulation F3. Hence, it can be concluded that the formulation F3 has potential to deliver metronidazole in a controlled and constant manner for prolong period over other formulations and can be adopted for a successful delivery of metronidazole for vaginal use.
机译:本研究涉及通过热变化法使用乙基纤维素的不同比例(1:1、1:2和1:4)制备甲硝唑微胶囊的开发和表征,以选择具有良好包封效率和稳定性的最佳微胶囊制剂。药物释放曲线。所获得的微胶囊是离散的,具有自由流动性质的球形,并对其粒度,形状,流动性质,壁厚,药物包封效率和体外释放性能进行了评估。通过FT-IR光谱和扫描电子显微镜研究了固态下的药物载体相互作用。尺寸范围在23-68μm的微胶囊显示出更高的封装效率。通过机械搅拌方法,将选定的微胶囊制剂MC3(药物聚合物比例为1:4)用于与多种卡波姆聚合物(carbopol-934、940、974和980)的凝胶制剂,以开发缓释微囊化的甲硝唑微胶囊含生物胶。评价所制备的生物粘附凝胶的pH,铺展性,可挤出性,粘度,阴道刺激性,体外药物释放,生物粘附,加速稳定性和体外药物释放动力学。体外实验表明,制剂F3可以持续释放24小时以上,并具有可接受的生物粘附质量。因此,可以得出结论,与其他制剂相比,制剂F3具有以受控且恒定的方式长时间递送甲硝唑的潜力,并且可以用于成功递送用于阴道的甲硝唑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号